Use of novel taurine-chitosan mediated liposomes for enhancing the oral absorption of doxorubicin via the TAUT transporter
Authors:
- 5 January 2024
- journal article
- research article
- Published by Elsevier in Carbohydrate Polymers
- Vol. 329, 121780
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- mTOR ensures increased release and reduced uptake of the organic osmolyte taurine under hypoosmotic conditions in mouse fibroblastsAmerican Journal of Physiology-Cell Physiology, 2014
- pH-Sensitive Micelles for Targeted Drug Delivery Prepared Using a Novel Membrane Contactor MethodACS Applied Materials & Interfaces, 2013
- Oral delivery of anticancer drugs: Challenges and opportunitiesJournal of Controlled Release, 2013
- Increasing Oral Absorption of Polar Neuraminidase Inhibitors: A Prodrug Transporter Approach Applied to Oseltamivir AnalogueMolecular Pharmaceutics, 2013
- Improvement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancerInternational Journal of Nanomedicine, 2011
- Modified Chitosans for Oral Drug DeliveryJournal of Pharmaceutical Sciences, 2009
- Taurine uptake across the human intestinal brush‐border membrane is via two transporters: H+‐coupled PAT1 (SLC36A1) and Na+‐ and Cl−‐dependent TauT (SLC6A6)The Journal of Physiology, 2009
- Regulation of taurine transport by Escherichia coli heat-stable enterotoxin and guanylin in human intestinal cell lines.Journal of Clinical Investigation, 1995
- Chloride-dependent amino acid transport in the small intestine: occurrence and significanceBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- Mechanisms underlying taurine-mediated alterations in membrane functionAmino Acids, 1995